Xizang Weixinkang Pharmaceutical: Received government subsidies related to revenue amounting to 34.3437 million yuan
On the evening of June 30, Xizang Weixinkang Pharmaceutical announced that on March 27 and June 30, the company and its wholly-owned subsidiary, Xizang Zhongwei Chengkang Pharmaceutical Co., Ltd., received a total of 34.3437 million yuan in enterprise development funds for 2024. This government subsidy is related to revenue and accounts for 13.95% of the company's net profit for the 2024 fiscal year
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments